银发经济浪潮下，祎泰药业以科技赋能智慧康养新未来

Group 1: Demographic Trends and Economic Impact - China's aging population is rapidly increasing, with projections indicating that by 2025, the population aged 60 and above will reach 310.31 million, accounting for 22% of the total population [1] - By 2035, the elderly population is expected to exceed 400 million, with an aging rate surpassing 30%, leading to a net annual increase of over 10 million people aged 60 and above [1] - The silver economy is projected to reach a scale of 19 trillion yuan by 2035, representing 28% of total consumption and 9.6% of GDP [1] Group 2: Market Growth in Medical Devices - The medical device market in China is expected to reach 111.03 billion yuan in 2024, with a forecasted growth to 180 billion yuan in 2025, reflecting a year-on-year increase of 13.5% [1] - From 2025 to 2030, the market is anticipated to grow at a compound annual growth rate (CAGR) of 8%-10%, increasing from 746.8 billion yuan to 1,346.7 billion yuan, a total increase of 81.1% [1] Group 3: Policy Support for Silver Economy - The Chinese government is promoting high-quality development of the silver economy through innovation, focusing on smart care robots, rehabilitation aids, and anti-aging industries [2] - Policies are aimed at integrating technology with the silver economy, emphasizing the development of smart home, wearable technology, and intelligent elderly care [2] Group 4: Company Profile - Yitai Pharmaceutical - Yitai Pharmaceutical has rapidly established itself as a benchmark in the elderly chronic disease medical device market since its inception in 2017, focusing on technology-driven health solutions [2] - The company’s core competitiveness lies in its technological innovation, particularly in its blood pressure monitoring products that combine the accuracy of the Korotkoff sound method with the stability of oscillometric methods [5] Group 5: Product Development and Future Plans - Yitai Pharmaceutical's blood pressure monitors utilize advanced signal processing technologies to ensure reliable measurements even in complex physiological conditions [5] - The company aims to enhance its service model by integrating artificial intelligence and big data analysis to create comprehensive health profiles and personalized care plans for users [6] - Future plans include expanding into international markets and leveraging a globalized approach to technology, aiming to benefit a larger elderly population [6]